Results 131 to 140 of about 58,749 (205)

Efficacy of recombinant bovine basic fibroblast growth factor gel combined with compound polymyxin B ointment on wound healing after fistulotomy. [PDF]

Medicine (Baltimore)
Long Q, Li Y.
europepmc   +1 more source

Microbiological and Infection-Source Predictors of Mortality in Severe Sepsis Patients Undergoing Polymyxin B Hemoperfusion: A Seven-Year Real-World Cohort Study. [PDF]

Life (Basel)
Chang WH, Kuo LK, Yu KP, Hu TY.
europepmc   +1 more source

Sequential Versus Non-Sequential Polymyxin B Hemoperfusion in Severe Sepsis and Septic Shock: A Real-World Cohort Analysis of Survival in an Asian ICU. [PDF]

Diagnostics (Basel)
Chang WH, Hu TY, Kuo LK.
europepmc   +1 more source

Hyperforin potentiates polymyxin B against multidrug-resistant Gram-negative pathogens via membrane disruption, biofilm eradication, and oxidative stress. [PDF]

Antimicrob Agents Chemother
Hussein M, Crawford S, Baker M, Floyd H, Allobawi R, Blaskovich MAT, Rao GG, Zuegg J, Li J, Velkov T.   +9 more
europepmc   +1 more source

Polymyxin B Hemoperfusion for Patients With Septic Shock Requiring High-Dose Norepinephrine: A Multicenter Prospective Cohort Study. [PDF]

Crit Care Explor
Kawazoe Y, Miyamoto K, Miyagawa N, Ohta Y, Yamamura H, Kimura T, Toyoda Y, Kyo M, Sato T, Kinjo M, Takahashi M, Maruyama J, Fukushima K, Matsuura H, Murata S, Okazaki T, Sakurai T, Suzuki T, Hanajima T, Takahashi G, Morimoto T.   +20 more
europepmc   +1 more source

Impact of Continuous Renal Replacement Therapy on Outcomes in Septic Shock Patients Receiving Polymyxin B Hemoperfusion: A Retrospective Cohort Study. [PDF]

Biomedicines
Chang WH, Yang SH, Shen HF, Hu TY, Wu WJ.   +4 more
europepmc   +1 more source

Clinical outcomes with lower versus conventional dose polymyxin B regimens in dialysis dependent and non-dialysis patients with gram-negative sepsis: A real-world propensity-score matched cohort study. [PDF]

PLoS One
Rajan AK, Shanbhag V, Kunhikatta V, Attur RP, Nelson B, S G VK, Chaudhuri S, Thunga G.   +7 more
europepmc   +1 more source

Synergistic activity of rifampicin and polymyxin B against intracellular Gram-negative ESKAPE pathogens involves bacterial membrane alterations and enhanced oxidative damages. [PDF]

Antimicrob Agents Chemother
Varik V, Wang G, Kritikos G, Banzhaf M, Drouot E, Koumoutsi A, Van Bambeke F.   +6 more
europepmc   +1 more source

The association between acute kidney injury and Polymyxin B treatment: A retrospective cohort study. [PDF]

Sci Prog
Wen L, Yuan X, Liu X, Jiang D, Liu L, Liu J.   +5 more
europepmc   +1 more source